FEDERICO
PULIDO ORTEGA
Profesor asociado de Ciencias de la Salud
University of the Witwatersrand
Johannesburgo, SudáfricaPublications in collaboration with researchers from University of the Witwatersrand (3)
2023
2021
-
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial
Infectious Diseases and Therapy, Vol. 10, Núm. 2, pp. 775-788
2019
-
Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial
The Lancet HIV, Vol. 6, Núm. 10, pp. e655-e666